Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Net Income towards Common Stockholders (2009 - 2026)

Revvity's (RVTY) quarterly Net Income towards Common Stockholders came in at $51.8 million in Q3 2026, down 3.94% on a YoY basis from $53.9 million in Q3 2025, and up 27.27% quarter-over-quarter from $40.7 million in Q2 2026.

Analysis

Revvity (RVTY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Net Income towards Common Stockholders for 18 consecutive years, with $51.8 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Net Income towards Common Stockholders fell 3.94% year-over-year to $51.8 million; the trailing twelve-month figure through Jul 2026 stood at $237.6 million (down 16.71% YoY), and the FY2025 full-year result was $241.2 million, down 10.79% from the prior year.
  • Net Income towards Common Stockholders advanced to $51.8 million in Q3 2026 per RVTY's latest filing, from $40.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $569.5 million in Q2 2023 and bottomed at $9.5 million in Q4 2023.
  • Historically, Net Income towards Common Stockholders has averaged $121.9 million across 5 years, with a median of $70.4 million in 2022.
  • The widest YoY moves for Net Income towards Common Stockholders: up 893.65% in 2024, down 95.43% in 2024.
  • Over 5 years, Net Income towards Common Stockholders stood at $85.3 million in 2022, then sank by 88.87% to $9.5 million in 2023, then jumped by 896.58% to $94.6 million in 2024, then climbed by 3.93% to $98.4 million in 2025, then tumbled by 47.32% to $51.8 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $51.8 million, $40.7 million, and $98.4 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 1.76 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 870.00 Mn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 362.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 207.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 51.82 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 54.62 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 371.40 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 5.01 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -17.93 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -62.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 51.82 Mn
Apr 5, 2026 40.72 Mn
Dec 28, 2025 98.36 Mn
Sep 28, 2025 46.65 Mn
Jun 29, 2025 53.95 Mn
Mar 30, 2025 42.24 Mn
Dec 29, 2024 94.65 Mn
Sep 29, 2024 94.37 Mn
Jun 30, 2024 55.36 Mn
Mar 31, 2024 26.01 Mn
Oct 1, 2023 9.50 Mn
Jul 2, 2023 35.56 Mn
Apr 2, 2023 569.48 Mn
Jan 1, 2023 227.98 Mn
Oct 2, 2022 85.35 Mn
Jul 3, 2022 179.21 Mn
Apr 3, 2022 176.96 Mn
Jan 2, 2022 305.80 Mn
Oct 3, 2021 127.74 Mn
Jul 4, 2021 239.31 Mn